Exploration of urine metabolic biomarkers for new-onset, untreated pediatric epilepsy: A gas and liquid chromatography mass spectrometry-based metabolomics study.
Tomoyuki AkiyamaDaisuke SaigusaTakushi InoueChiho TokorodaniMari AkiyamaRie MichiueAtsushi MoriEiji HishinumaNaomi MatsukawaTakashi ShibataHiroki TsuchiyaKatsuhiro KobayashiPublished in: Brain & development (2024)
Urine metabolome analysis, which covers a larger number of metabolites than conventional biochemistry analyses, found no consistently altered small molecule metabolites except for reduced taurine in epilepsy patients compared to healthy controls. Further studies with larger samples, subjects with different ages, expanded target metabolites, and the investigation of plasma samples are required.
Keyphrases
- mass spectrometry
- liquid chromatography
- small molecule
- ms ms
- end stage renal disease
- high resolution mass spectrometry
- chronic kidney disease
- newly diagnosed
- ejection fraction
- tandem mass spectrometry
- high resolution
- high performance liquid chromatography
- peritoneal dialysis
- prognostic factors
- gas chromatography
- protein protein
- simultaneous determination
- case control
- room temperature
- temporal lobe epilepsy
- carbon dioxide